Framingham CHD Risk (Hard Endpoints)

About Framingham CHD Risk (Hard Endpoints)

Framingham CHD Risk (Hard Endpoints, Wilson 1998)

The Framingham Hard CHD Risk Score, published by Wilson and colleagues in Circulation in 1998, is the original point-based coronary heart disease risk estimator and the foundation on which most subsequent cardiovascular risk calculators were built. It uses a simple additive scoring system in which each risk factor is assigned integer points based on look-up tables, and the total points map to a 10-year probability of coronary heart disease death or nonfatal myocardial infarction. The endpoint is intentionally narrow, only 'hard' CHD events, to maximize clinical specificity and to avoid the noise of angina or coronary revascularization that can be subject to ascertainment bias.

What the calculator measures

The output is a single percent: the probability of coronary death or nonfatal MI within the next 10 years. The original Framingham ATP III implementation stratified risk into three tiers used by the National Cholesterol Education Program: Low (<10%), Intermediate (10-20%), and High (>20%). Patients in the High tier were considered 'CHD risk equivalents' and treated to secondary-prevention LDL targets, a framework that shaped two decades of lipid management until the 2013 ACC/AHA guideline shifted to statin benefit groups.

How the formula works

The Wilson 1998 score is a sex-stratified Cox proportional hazards model whose coefficients have been rounded into integer point values for ease of bedside use. Points accrue for age (the dominant factor, 0 points at age 40-44 for men, scaling up to 13 points at age 75-79), total cholesterol (stratified into 5 bands), HDL cholesterol (more points for lower HDL), systolic blood pressure (separate tables for treated and untreated), and smoking status (2 points for current smoking in both sexes). The points are summed, and the total is mapped to a 10-year probability via sex-specific look-up tables that range from 1% at very low scores to 85% at the highest scores. The point-table approach is mathematically equivalent to a Cox model with categorized predictors but trades some precision for interpretability. A second version of the score (D'Agostino 2008 general CVD) replaced the categorized approach with continuous log-transformed values, but the original Wilson 1998 point version remains in wide use because of its transparency and ease of manual calculation.

Interpretation

The original Framingham CHD score was the engine of NCEP ATP III, which used the 20% threshold to define 'CHD risk equivalents', patients who, despite never having had a heart attack, were treated as if they had established coronary disease. The 10% threshold defined the boundary between '2 or more risk factors' (which warranted LDL-lowering therapy if LDL was ≥130 mg/dL) and '0-1 risk factors' (which warranted lifestyle therapy alone unless LDL was ≥190 mg/dL). This framework drove the statin prescribing culture of the 2000s and remains influential in many guidelines outside the United States.

Clinical use

The hard-CHD score is most useful when the question is specifically about coronary events (rather than the broader cardiovascular endpoint of the D'Agostino 2008 score). It is the score used in the NCEP ATP III risk stratification that still underlies the lipid guidelines of many countries (Canada, China, Japan, parts of Latin America). The point-table format is also pedagogically valuable: clinicians can show patients exactly which risk factor contributes how many points, and how modifying each factor (smoking cessation = -2 points; lowering SBP from 150 to 120 mmHg = -3 points; raising HDL from 35 to 55 mg/dL = -3 points) translates into reduced risk.

Limitations

The Wilson 1998 score shares the limitations of all Framingham-derived tools: derivation in a predominantly white, Massachusetts-based cohort; overestimation of risk in some non-white populations; absence of family history, BMI, diabetes (the original score excluded diabetics as already high-risk), and biomarkers like hs-CRP, Lp(a), or apoB. The score also does not include stroke or heart failure, endpoints that are clinically important, particularly in older women and Black patients. For this reason, modern guidelines prefer the broader ASCVD or general CVD scores for primary prevention decisions.

Comparison with newer scores

Compared with the 2013 ACC/AHA Pooled Cohort Equations, the Wilson 1998 score typically yields slightly lower 10-year risk estimates because it counts only hard CHD events (MI and coronary death) rather than the broader ASCVD endpoint (which adds stroke). Compared with the D'Agostino 2008 general CVD score, it counts fewer endpoints (no angina, no stroke, no PAD, no heart failure) and uses categorical rather than continuous risk factors. The original Wilson score has largely been superseded by these newer scores for primary prevention decisions but remains valuable for historical continuity, for coronary-specific risk assessment, and for educational use.

How to use the result

A hard-CHD risk of 12% means that approximately 12 out of 100 individuals with the same risk factor profile will experience a heart attack or die of coronary heart disease within the next decade. The result is most actionable when paired with a discussion of modifiable risk factors. Smoking cessation within 1 year reduces CHD risk by approximately 50%; lowering SBP by 10 mmHg reduces CHD events by approximately 20-25%; reducing LDL-C by 39 mg/dL with a statin reduces major coronary events by approximately 23%. These numbers, communicated alongside the absolute risk estimate, help patients understand the magnitude of benefit from intervention.